Home
About IBT
IBT History
Management
Board of Directors
Advisory Board
Sustainability Policy
Pipeline
IBP-9414
IBP-1016
IBP-1118
IBP-1122
Families
Healthcare Professionals
Investors & Media
Shares
Presentations
Share Issue
Ownership Structure
Corporate Governance
Calendar
Financial Reports
Press Releases
Investors & Media Contact
Subscribe
Contact Us
Career
En
Sv
Home
About IBT
IBT History
Management
Board of Directors
Advisory Board
Sustainability Policy
Pipeline
IBP-9414
IBP-1016
IBP-1118
IBP-1122
Families
Healthcare Professionals
Investors & Media
Shares
Presentations
Share Issue
Ownership Structure
Corporate Governance
Calendar
Financial Reports
Press Releases
Investors & Media Contact
Subscribe
Contact Us
Career
Press releases
Prospectus relating to Infant Bacterial Therapeutics’ rights issue published
January 10, 2018
To access the press release, please read the following disclaimer
here
.
Latest press releases
2024-12-20 16:33
IBT Continues Development of Drug Candidate IBP-9414
2024-11-14 08:30
Infant Bacterial Therapeutics AB (publ) Interim report January 1 – September 30, 2024
Regulatory
2024-10-23 09:00
Infant Bacterial Therapeutics to present at FDA workshop in the USA
2024-10-09 09:00
Infant Bacterial Therapeutics AB (publ) announces the appointment of the Nomination Committee for the Annual General Meeting 2025
Regulatory
2024-09-01 19:27
IBT invites you to a virtual meeting/call on Tuesday, September 3rd, 2024, at 4 pm CET, to discuss the recent results from the Connection Study.